Abstract
Data on actual harm of magic mushrooms suggest that toxicity and abuse potential is low, however, their legal status suggests otherwise. We aimed to gauge perception of harm of magic mushrooms in both users and mushroom-naïve participants. We also aimed to observe differences in expectations of effects between users and mushroom-naïve participants, and whether motivations for use predicted their expected effects. In total, 73 polydrug users with experience of using magic mushrooms and 78 mushroom-naïve participants completed an online survey. We asked participants to rank a list of 10 substances from most dangerous to least dangerous and questioned them about expectation of effect using a modified magic mushroom expectation questionnaire. Users were asked about their motivations for using magic mushrooms. Both groups perceive mushrooms to be safer than heroin, cocaine, prescription painkillers, gamma-hydroxybutyrate (GHB), ecstasy, tobacco and alcohol. However, the mushroom-naïve group ranked mushrooms as significantly more dangerous than the user group. Non-users reported greater expectancy for negative intoxication. Users reported greater expected entactogenic, prosocial, aesthetic and mood effects, and perceptual alterations...Continue Reading
References
Oct 1, 1986·Journal of Psychoactive Drugs·D E Nichols
Oct 1, 1984·The Journal of Nervous and Mental Disease·R J Strassman
Jun 28, 2003·Journal of Natural Products·Osamu ShirotaYukihiro Goda
Oct 28, 2003·Addiction Biology·Torsten PassieHinderk M Emrich
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Apr 21, 2004·Behavioural Pharmacology·W E FantegrossiG Winger
Jan 25, 2005·Drug and Alcohol Dependence·Alex GammaHarry R Sumnall
Jan 13, 2006·Journal of Psychopharmacology·Harry R SumnallLisa Jerome
Jul 3, 2008·Journal of Psychopharmacology·Mw JohnsonRr Griffiths
Sep 22, 2010·Journal of Psychopharmacology·Erich StuderusFranz X Vollenweider
Nov 3, 2010·Lancet·David J NuttUNKNOWN Independent Scientific Committee on Drugs
Jan 25, 2011·Regulatory Toxicology and Pharmacology : RTP·Jan van AmsterdamWim van den Brink
Jan 1, 2014·Journal of Psychoactive Drugs·Robin Lester Carhart-Harris, David John Nutt
Jan 22, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Filip TylšJiří Horáček
May 24, 2016·The Lancet. Psychiatry·Robin L Carhart-HarrisDavid J Nutt
Dec 3, 2016·Journal of Psychopharmacology·Stephen RossBrian L Schmidt
Dec 3, 2016·Journal of Psychopharmacology·Roland R GriffithsMargaret A Klinedinst
Jan 12, 2017·Drug Metabolism Reviews·Ricardo Jorge Dinis-Oliveira
May 27, 2017·Clinical Pharmacology and Therapeutics·E M Sellers
Sep 16, 2017·Statistics in Medicine·Peter C Austin, Jason P Fine
Nov 10, 2017·Psychopharmacology·R L Carhart-HarrisD J Nutt
May 14, 2018·Neuropharmacology·Matthew W JohnsonJack E Henningfield
Dec 15, 2018·Journal of Forensic Sciences·Emma HonyigloLaurent Fanton
May 14, 2019·Journal of Psychopharmacology·Yvonne BonomoDavid Castle